Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (68 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 29 Dec 2015 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Mirae Asset ELSS Tax Saver Fund |
|---|---|
| 29 Dec 2015 | ₹100.00 |
| 17 Nov 2016 | ₹116.63 |
| 07 Oct 2017 | ₹153.13 |
| 27 Aug 2018 | ₹161.63 |
| 17 Jul 2019 | ₹161.01 |
| 05 Jun 2020 | ₹143.59 |
| 25 Apr 2021 | ₹207.12 |
| 14 Mar 2022 | ₹248.04 |
| 01 Feb 2023 | ₹238.05 |
| 22 Dec 2023 | ₹257.40 |
| 10 Nov 2024 | ₹313.28 |
| 30 Sep 2025 | ₹299.79 |
| 20 Aug 2026 | ₹270.83 |
| Metric | Mirae Asset · Direct · IDCW NAV ₹27.16 Very High risk ★★☆☆☆ | Category median ELSS · 68 funds |
|---|---|---|
| -10.56% | +2.22% | |
| +5.69% | +9.76% | |
| +2.18% | +8.88% | |
| +8.65% | +10.68% | |
| +9.81% | +10.64% | |
| +1.30% | — | |
| +10.47% | +11.55% | |
| +11.55% | +12.14% | |
| +9.87% | +10.94% | |
| Risk | ||
| 16.73% | 14.08% | |
| -0.05 | 0.32 | |
| -0.06 | 0.44 | |
| -39.37% | -35.52% | |
| Nifty 500 | — | |
| -5.48% | -1.42% | |
| 1.01 | 0.96 | |
| 92.9% | 91.4% | |
| 128.0% | 94.7% | |
| 1.02% | 1.17% | |
| ₹25,328Cr | ₹694.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 69% | 33% | |
| Neelesh Surana · 10.8y | — | |
| 29 Dec 2015 | — | |
| 66 | — | |
| 40.5% | — | |
| 0.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.